Image source: Getty Images With the FTSE 100 trading above 9,000 points and pushing to fresh record highs, it’s no wonder that many investors are cheering. Yet, when I examine the current macroeconomic backdrop, I can identify several warning signs that could lead to a stock market crash later this year. Here are some of them, and why I’m not actually worried. Inflation trending higher The latest UK inflation figure showed prices rising by 3.6%, the highest level in well over a year. When I look at the previous months, it’s clear that inflation’s trending higher. This isn’t a good…
Author: user
Interest in Greenland’s minerals is soaring, driven in part by Trump, who has said the U.S. must “get” the island. But the rare earths will be hard to mine. Source link
The European Union is reintroducing international carbon credits into its climate policy to help meet its 2040 carbon emission targets.The effectiveness of international carbon credits depends on ensuring environmental integrity, fair benefit-sharing and alignment with the Paris Agreement.Used responsibly, international carbon credits can support a just transition in the Global South while also benefiting European industries.Twelve years after phasing out the use of carbon credits towards its climate goals, the EU is now considering reintroducing them. A proposed amendment to EU climate law would set a legally binding target to cut net greenhouse gas emissions by 90% by 2040, compared…
Image source: Getty Images This time last year I declared two FTSE 100 income giants, Legal & General Group (LSE: LGEN) and M&G (LSE: MNG), my favourite two dividend shares. Have they lived up to expectations? On 29 July 2024, they were offering spectacular yields of 8.76% and 9.43% respectively. Yet I was also a little frustrated. Their shares had dipped over 12 months, eroding my income gains. I thought they’d been unfairly ignored. Was I right? M&G share price climbs nicely Over the last year, the M&G share price has risen an impressive 26.5%. That’s terrific for a big blue-chip. Legal & General couldn’t…
NEW PHILADELPHIA ‒ The New Philadelphia City Schools Board of Education has voted to place a 6.1-mill bond issue on the Nov. 4 ballot.This is the third attempt by the district to get a bond issue passed. On May 6, district voters rejected by a wide margin a $72-million, 5.9-mill bond issue to fund construction of a new elementary school at South Elementary and eventually a new high school/middle school at the current site. The bond issue was also rejected by voters in November.The updated millage reflects increased construction costs due to inflation and higher interest rates since the previous…
raw material and mineral rare earth news Source link
July 28, 2025 – TheNewswire – TORONTO, ON – Star Royalties Ltd. (“Star Royalties”, or the “Company”) (TSXV: STRR, OTCQX: STRFF), through its joint … Source link
(TheNewswire)July 28, 2025 – TheNewswire – TORONTO, ON – Star Royalties Ltd.(“Star Royalties”, or the“Company”) (TSXV: STRR,OTCQX: STRFF), through its joint venture, Green Star Royalties Ltd.(“Green Star”), is pleasedto highlight NativState LLC’s (“NativState”)announcement of a strategic agreement with TotalEnergies SE(“TotalEnergies”) TTE, whereby TotalEnergies will acquire thecarbon credits generated by 13 of NativState’s Improved ForestManagement (“IFM”) projects in the southeastern United States. NativStateis an Arkansas-based forest carbon project developer focused onaggregating small-to-medium forest landowners into IFM projects beingdeveloped under the American Carbon Registry (“ACR”). GreenStar has a portfolio of royalties on NativState’s IFM projects,which span 78,000 acres across Arkansas, Louisiana, Mississippi andMissouri.HighlightsLarge-scale…
Image source: Getty Images The FTSE 100 may be charging higher right now, but that doesn’t mean there aren’t still good opportunities out there for long-term investors. With this in mind, here are two Footsie stocks I reckon deserve closer attention. Healthcare blue-chip Pharmaceutical giant AstraZeneca‘s (LSE: AZN) currently the largest listed UK firm, with a market-cap of £169.3bn. And that’s despite a share price drop of 12% over the past year (versus a 10% rise for the FTSE 100). This immediately points to an issue that’s currently hanging over the pharma industry, which is the threat of US tariffs.…
Image source: Getty Images The FTSE 250 hasn’t exactly thrilled this year, but one company I’ve been quietly watching is still ticking over nicely: Goodwin (LSE: GDWN). On 10 June, I wrote about this family-run engineering firm that’s returned an astonishing 4,632% over the last two decades. Since then, nothing big has happened, and the shares have drifted a little. That suits me. With the results due in early August (probably around the 6th or 7th), I’ve got a window to act. Long-term story intact The Goodwin share price is actually down 5% over the past year, which doesn’t scream momentum. But over three…